Point Biopharma Global Inc
(PNT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PNT | NTLA | RAPP | ||
| Company | Point Biopharma Global Inc | Intellia Thera CS | Rapport Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 12.50 | 12.16 | 28.26 | ||
| High | 12.51 | 12.16 | 28.86 | ||
| Low | 12.49 | 12.16 | 26.57 | ||
| Latest | 12.50 | 11.85 | 28.03 | ||
| Change | +0.02 | -0.15 | +0.39 | ||
| % Change | +0.16% | -1.25% | +1.41% | ||
| Volume | 3,290,900 | 14,389 | 191,600 | ||
| 20-Day Average Volume | 4,214,580 | 5,964,564 | 315,735 | ||
| Previous Close | 12.48 | 12.00 | 28.25 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 13.45 | 13.09 | 26.97 | ||
| 20-Day Raw Stochastic | 3.65% | 19.90% | 64.29% | ||
| 20-Day Relative Strength | 42.56 | 50.64 | 50.30 | ||
| Weighted Alpha | +4.80 | +88.68 | +19.39 | ||
| Today's Opinion | 56% Buy | 16% Sell | 40% Buy | ||
| Previous Opinion | 56% Buy | 16% Sell | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 8% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.40% since 12/18/23 | +9.65% since 02/05/26 | +4.56% since 02/04/26 | ||
| Low | 12.43 on 12/19/23 | 11.32 on 02/06/26 | 25.21 on 02/05/26 | ||
| High | 12.51 on 12/26/23 | 12.54 on 02/10/26 | 28.99 on 02/10/26 | ||
| 1-Month | |||||
| %Chg | -9.16% since 11/24/23 | +6.39% since 01/12/26 | -4.56% since 01/09/26 | ||
| Low | 12.43 on 12/19/23 | 10.94 on 02/05/26 | 25.21 on 02/05/26 | ||
| High | 14.35 on 12/13/23 | 17.09 on 01/27/26 | 29.00 on 01/12/26 | ||
| 3-Month | |||||
| %Chg | +83.28% since 09/26/23 | +28.13% since 11/12/25 | +8.39% since 11/11/25 | ||
| Low | 6.57 on 10/02/23 | 7.95 on 11/21/25 | 23.75 on 11/17/25 | ||
| High | 14.35 on 12/13/23 | 17.09 on 01/27/26 | 32.36 on 12/23/25 | ||
| 6-Month | |||||
| %Chg | +37.67% since 06/26/23 | +11.97% since 08/12/25 | +93.56% since 08/11/25 | ||
| Low | 6.57 on 10/02/23 | 7.95 on 11/21/25 | 13.86 on 08/19/25 | ||
| High | 14.35 on 12/13/23 | 28.25 on 10/20/25 | 42.27 on 09/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,332,113 | 1,389,960 | 1,317,350 | ||
| Shares Outstanding, K | 106,569 | 115,830 | 47,661 | ||
| Annual Sales | 226,580,000 | 57,880,000 | 0 | ||
| Annual Net Income | 98,290,000 | -519,020,000 | -78,310,000 | ||
| Last Quarter Sales | 2,790,000 | 13,780,000 | 0 | ||
| Last Quarter Net Income | -24,770,000 | -101,320,000 | -26,930,000 | ||
| 60-Month Beta | 0.00 | 2.10 | 1.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.23 on 11/13/23 | -0.92 on 11/06/25 | -0.71 on 11/06/25 | ||
| Latest Earnings Date | 03/25/24 | 02/26/26 | 03/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 13.87 | 0.00 | 0.00 | ||